{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:49:23Z","timestamp":1769600963453,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.radonc.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T09:36:26Z","timestamp":1462008986000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review"],"prefix":"10.1016","volume":"119","author":[{"given":"Karlijn H.J.","family":"Groenen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Pouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerjon","family":"Hannink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allard J.F.","family":"Hosman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette M.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Verdonschot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Tanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.03.001_b0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"3","author":"Coleman","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2016.03.001_b0010","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"8","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpainsymman.2007.01.001","article-title":"Managing metastatic bone pain: the role of bisphosphonates","volume":"4","author":"Gralow","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.radonc.2016.03.001_b0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","article-title":"Impact of skeletal complications on patients\u2019 quality of life, mobility, and functional independence","volume":"8","author":"Costa","year":"2008","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0025","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/02841860310014895","article-title":"A systematic overview of radiation therapy effects in skeletal metastases","volume":"5\u20136","author":"Falkmer","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1302\/0301-620X.86B4.14703","article-title":"Comparative analysis of risk factors for pathological fracture with femoral metastases","volume":"4","author":"Van der Linden","year":"2004","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.radonc.2016.03.001_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3322\/CA.2007.0016","article-title":"Spinal extradural metastasis: review of current treatment options","volume":"4","author":"Bartels","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2016.03.001_b0040","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group","volume":"22","author":"Fisher","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.radonc.2016.03.001_b0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","article-title":"Bone metastases: pathophysiology and management policy","volume":"3","author":"Nielsen","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0050","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"7041","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2016.03.001_b0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2106\/JBJS.I.00919","article-title":"The assessment of fracture risk","volume":"3","author":"Unnanuntana","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.radonc.2016.03.001_b0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: a systematic review","volume":"11","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","article-title":"Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial","volume":"2","author":"Chow","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.radonc.2009.05.012","article-title":"8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial","volume":"2","author":"Maranzano","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0075","first-page":"CD004721","article-title":"Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy \u2013 a systematic review of the randomised trials","volume":"2","author":"Sze","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2016.03.001_b0080","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0360-3016(02)04147-0","article-title":"Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases","volume":"3","author":"Wu","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.03.001_b0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s000660050061","article-title":"Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3Gy vs. 1 time 8Gy). A prospective study","volume":"10","author":"Koswig","year":"1999","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.03.001_b0090","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s00520-012-1563-z","article-title":"Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis","volume":"11","author":"Lopez-Olivo","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0095","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.clinthera.2009.05.009","article-title":"Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials","volume":"5","author":"Machado","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.radonc.2016.03.001_b0100","first-page":"CD003474","article-title":"Bisphosphonates for breast cancer","volume":"3","author":"Pavlakis","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2016.03.001_b0105","first-page":"CD006250","article-title":"Bisphosphonates for advanced prostate cancer.","volume":"4","author":"Yuen","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2016.03.001_b0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"6937","author":"Boyle","year":"2003","journal-title":"Nat New Biol"},{"key":"10.1016\/j.radonc.2016.03.001_b0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrclinonc.2010.17","article-title":"Treatment of painful bone metastases","volume":"4","author":"Rades","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"4","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.radonc.2016.03.001_b0125","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"9","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.radonc.2016.03.001_b0130","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/j.oooo.2012.01.046","article-title":"Review of current literature and implications of RANKL inhibitors for oral health care providers","volume":"6","author":"Epstein","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.radonc.2016.03.001_b0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0305-7372(03)00013-6","article-title":"Bisphosphonates and radiation therapy for palliation of metastatic bone disease","volume":"4","author":"Hoskin","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2016.03.001_b0140","unstructured":"Effective Public Health Practice Project. Quality Assessment Tool for Quantitative Studies. Last accessed 2015 February 20. Available from: http:\/\/www.ephpp.ca\/PDF\/Quality%20Assessment%20Tool_2010_2.pdf."},{"key":"10.1016\/j.radonc.2016.03.001_b0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jso.20949","article-title":"Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis","volume":"3","author":"Arrington","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00223-010-9390-z","article-title":"Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy","volume":"3","author":"Arrington","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.radonc.2016.03.001_b0155","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cncr.11646","article-title":"Combination of early bisphosphonate administration and irradiation leads to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model","volume":"6","author":"Krempien","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00520-009-0663-x","article-title":"Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study","volume":"6","author":"Atahan","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3171\/2012.8.SPINE12303","article-title":"Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma","volume":"6","author":"Balagamwala","year":"2012","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2016.03.001_b0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11060-014-1463-9","article-title":"Clinical result of stereotactic radiosurgery for spinal metastasis from hepatocellular carcinoma: comparison with conventional radiation therapy","volume":"1","author":"Chang","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0175","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/1097-0142(19800401)45:7<1533::AID-CNCR2820450703>3.0.CO;2-Y","article-title":"Nonoperative management of femoral, humeral, and acetabular metastases in patients with breast carcinoma","volume":"7","author":"Cheng","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2004.01.009","article-title":"Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy\u2013a feasibility study","volume":"3","author":"Chow","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0185","first-page":"223","article-title":"Clinical studies of the quantitative changes in mineral salt content of irradiated vertebral body metastases with 2-energy computerized tomography","volume":"6","author":"Crone-Munzebrock","year":"1988","journal-title":"Rontgenblatter"},{"key":"10.1016\/j.radonc.2016.03.001_b0190","first-page":"389","article-title":"The effect of a single fraction compared to multiple fractions radiotherapy on painful bone metastases with evaluation of computed tomography bone density in osteolytic bone metastases","volume":"2","author":"El-Shenshawy","year":"2006","journal-title":"Bull Alex Fac Med"},{"key":"10.1016\/j.radonc.2016.03.001_b0195","article-title":"Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis","volume":"62","author":"Foerster","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/126.1.235","article-title":"The effectiveness of radiation therapy in the treatment of bone metastases from breast cancer","volume":"1","author":"Garmatis","year":"1978","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2016.03.001_b0205","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnci\/dji139","article-title":"Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases","volume":"11","author":"Hartsell","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2016.03.001_b0210","first-page":"1279","article-title":"Osseous metastases in breast cancer: radiographic monitoring of therapeutic response","volume":"2B","author":"Huber","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2016.03.001_b0215","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1464-410X.2008.08124.x","article-title":"Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate","volume":"5","author":"Kijima","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.radonc.2016.03.001_b0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0360-3016(03)00525-X","volume":"1","author":"Kouloulias","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.03.001_b0225","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jjco\/hyt050","article-title":"High-dose radiotherapy using helical tomotherapy for vertebral metastasis: early clinical outcomes and cord dose specification","volume":"6","author":"Lee","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3857\/roj.2015.33.3.217","article-title":"Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma","volume":"3","author":"Lee","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0235","article-title":"Computed tomography evaluation of density following stereotactic body radiation therapy of nonspine bone metastases","author":"McDonald","year":"2015","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2016.03.001_b0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0167-8140(95)01520-Q","article-title":"Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up","volume":"3","author":"Rasmusson","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/BLO.0b013e3180616594","article-title":"Radiotherapy to bone has utility in multifocal metastatic renal carcinoma","author":"Reichel","year":"2007","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.radonc.2016.03.001_b0250","first-page":"221","article-title":"Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancer","volume":"4","author":"Rhee","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0255","first-page":"23","article-title":"Accelerated irradiation of bone metastases","volume":"1","author":"Rieden","year":"1989","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.03.001_b0260","first-page":"380","article-title":"The radiotherapeutic effect on bone metastases in relation to the frequency of metastases, sites of metastases and histology of the primary tumor","volume":"5","author":"Rieden","year":"1989","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.03.001_b0265","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1748-717X-8-200","article-title":"The stability of osseous metastases of the spine in lung cancer \u2013 a retrospective analysis of 338 cases","volume":"1","author":"Rief","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0270","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00066-014-0651-z","article-title":"Stability of spinal bone metastases in breast cancer after radiotherapy: a retrospective analysis of 157 cases","volume":"9","author":"Schlampp","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.03.001_b0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3171\/2014.9.SPINE1482","article-title":"Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma","volume":"1","author":"Sellin","year":"2015","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2016.03.001_b0280","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-014-1455-9","article-title":"Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study","volume":"1","author":"Sohn","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(99)00110-3","article-title":"The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study","volume":"2","author":"Steenland","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0290","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbo.2014.02.003","article-title":"Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI","volume":"1","author":"Switlyk","year":"2014","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0295","first-page":"541656","article-title":"Radiotherapy for oligometastases and oligo-recurrence of bone in prostate cancer","author":"Tabata","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.radonc.2016.03.001_b0300","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s00776-012-0294-9","article-title":"Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up","volume":"6","author":"Takeda","year":"2012","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.radonc.2016.03.001_b0305","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3171\/2014.7.SPINE13895","article-title":"Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture","volume":"5","author":"Thibault","year":"2014","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2016.03.001_b0310","article-title":"Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes","author":"Ursino","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.radonc.2016.03.001_b0315","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijrobp.2006.08.022","article-title":"Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment","volume":"1","author":"Vassiliou","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.03.001_b0320","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10585-007-9066-x","article-title":"A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate","volume":"3","author":"Vassiliou","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.radonc.2016.03.001_b0325","first-page":"332","article-title":"The remineralization of the vertebral metastases of breast carcinoma after radiotherapy","volume":"6","author":"Wachenfeld","year":"1996","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2016.03.001_b0330","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2007-1023684","article-title":"Radiotherapy of osseous metastases in breast cancer","volume":"2","author":"Wagner","year":"1991","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.radonc.2016.03.001_b0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-8140(03)00232-9","article-title":"Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomised trial","volume":"1","author":"van der Linden","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0340","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s001980200000","article-title":"Biomechanics of bone: determinants of skeletal fragility and bone quality","volume":"2","author":"Turner","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.radonc.2016.03.001_b0345","article-title":"A multicenter randomized trial of ibandronate compared with single-dose radiotherapy for localized metastatic bone pain in prostate cancer","volume":"10","author":"Hoskin","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2016.03.001_b0350","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"9768","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.03.001_b0355","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"16","author":"Lipton","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.03.001_b0360","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"35","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.03.001_b0365","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00066-012-0158-4","article-title":"Impact of zoledronic acid on control of metastatic spinal cord compression","volume":"10","author":"Rades","year":"2012","journal-title":"Strahlenther Onkol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016001237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016001237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T01:39:58Z","timestamp":1567820398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0167814016001237"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.03.001","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of radiotherapy, and radiotherapy combined with bisphosphonates or RANK ligand inhibitors on bone quality in bone metastases. A systematic review","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}